NatWest Group plc

Position in JNJ — Johnson & Johnson

CIK 844150 EDINBURGH, SCOTLAND, X0

Position in JNJ

as of Jun 30, 2026 · filed Aug 10, 2026 Compact

Position Value

$239,493

-$10,267,026 QoQ

Shares Held

943

-97.8% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

#4,371

of 4,664 holders

Holding Since

Mar 2020

15 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

NatWest Group plc holds $63,512,390 across 5 Drug Manufacturers - General names. JNJ ranks #5 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AZN	Astrazeneca PLC	210,470	$39,909,321
2	AMGN	Amgen Inc	31,140	$11,276,416
3	GILD	Gilead Sciences, Inc.	49,485	$6,251,934
4	LLY	ELI LILLY & Co	4,865	$5,835,226
5	JNJ	Johnson & Johnson This page	943	$239,493

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$239,493	943	-97.8%	Shares	Defined	2026-08-10
2026-03-31	$10,506,519	42,982	-25.1%	Shares	Defined	2026-05-11
2025-12-31	$11,874,997	57,381	+4.7%	Shares	Defined	2026-01-13
2025-09-30	$10,161,571	54,803	+2154.3%	Shares	Defined	2025-10-08
2023-06-30	$402,379	2,431	+49.3%	Shares	Defined	2023-07-25
2022-06-30	$288,986	1,628	-14.0%	Shares	Defined	2022-07-20
2022-03-31	$335,673	1,894	-42.8%	Shares	Defined	2022-05-03
2021-12-31	$566,925	3,314	-68.2%	Shares	Defined	2022-02-07
2021-09-30	$1,683,476	10,424	-9.8%	Shares	Defined	2021-10-26
2021-06-30	$1,903,735	11,556	-10.1%	Shares	Defined	2021-07-21
2021-03-31	$2,113,047	12,857	-15.6%	Shares	Defined	2021-04-16
2020-12-31	$2,397,684	15,235	-24.2%	Shares	Defined	2021-02-04
2020-09-30	$2,993,232	20,105	-5.6%	Shares	Defined	2020-11-10
2020-06-30	$2,995,277	21,299	-5.0%	Shares	Defined	2020-07-16
2020-03-31	$2,939,540	22,417	—	Shares	Defined	2020-05-07
No filing history on record for this holder in this stock.